Abstract
Serum amino acid pattern, blood ammonia, and serum valproic acid (VPA) levels were estimated in 75 epileptic children with and without VPA therapy. The incidence of patients with hyperammonaemia (>60 μmol/l) in patients treated with only VPA or with a combination of VPA and other antiepileptic drugs was 19% and 20% respectively. Hyperammonaemia was not observed in patients receiving other drugs. Elevated levels of serum glycine, alanine and serine were more common in epileptic patients treated with VPA alone and with VPA in combination with other drugs than in patients receiving other drugs. A significant positive correlation was found between the serum levels of glycine and alanine, of glycine and serine, and of serine and alanine. These findings may indicate a mitochondrial dysfunction caused by VPA.
Similar content being viewed by others
Abbreviations
- VPA:
-
valproic acid
References
Addison GM, Gordon NS (1980) Sodium valproate and acute hepatic failure. Dev Med Child Neurol 22:248–249
Bartlet K (1977) Sodium valproate and hyperglycinaemia. Lancet II:716
Benavides J, Martin A, Ugarte M, Valdivieso F (1982) Inhibition by valproic acid of pyruvate uptake by brain mitochondria. Biochem Pharmacol 31:1633–1636
Coude FX, Rabier D, Cathelineau L, Grimber G, Parvy P, Kamoun PP (1981) A mechanism for valprote-induced hyperammonemia. Pediatr Res 15:974–975
Committee on Drugs (1982) Valproic acid: benefits and risks. Pediatrics 70:316–319
Coulter DL, Allen RJ (1981) Hyperammonemia with valproic acid therapy. J Pediatr 99:317–319
Donat JF, Bocchini JA Jr, Gonzalez E, Schwendimann RN (1979) Valproic acid and fatal hepatitis. Neurology 29:273–274
Dreifuss FE, Santilli N, Langer DH, Sweeny KP, Moline KA, Menander KB (1987) Valproic acid hepatic fatalities: a retrospective review. Neurology 37:379–385
Gastaut H, Noel P (1981) A case of fatal toxic hepatitis: recommendations for the administration of sodium valproate. Epilepsia 22:711–713
Gerber N, Dickinson RG, Harland RC, Lynn RK, Houghton D, Antonias JI, Schimschock JC (1979) Reye-like syndrome associated with valproic acid therapy. J Pediatr 95:142–144
Haas R, Chir B, Stumph DA, Parks JK, Eguren L (1981) Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31:1473–1476
Hayasaka K, Kochi H, Hiraga K, Kikuchi G (1980) Occurrence of a catalytically less active glycine decarboxylase in the liver of rat treated with dipropylacetic acid. Biochem Int 1:410–416
Hayasaka K, Takahashi I, Kobayashi Y, Iinuma K, Narisawa K, Tada K (1986) Effects of valproate on biogenesis and function of liver mitochondria. Neurology 36:351–356
Herranz JL, Arteaga R, Armijo JA (1982) Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients. Epilepsia 23:203–214
Hjelm M, Oberholzer V, Seakins J, Thomas S, Kay JDS (1986) Valproate-induced inhibition of urea synthesis and hyperammonaemia in healthy subjects. Lancet II:859
Jacobi G, Thorbeck R, Rits A, Janssen W, Schmidts H (1980) Fatal hepatotoxicity in child on phenobarbitone and sodium valproate. Lancet I:712–713
Jaeken J, Corbeel L, Casaer P, Carchon H, Eggermont E, Eeckels R (1977) Dipropylacetate (valproate) and glycine metabolism. Lancet I:617
Kochi H, Hayasaka K, Hiraga K, Kikuchi G (1979) Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Arch Biochem Biophys 198:589–597
LeBihan G, Bourreille J, Sompson M, Leroy J, Szekely AM, Coquerel A (1980) Fatal hepatic failure and sodium valproate. Lancet II:1298–1299
Lenoir GR, Perignon J-L, Gubler M-C, Broyer M (1981) Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr 98:502–504
Okuda H, Fujii S (1966) A direct electrophotometoric method of blood ammonia analysis (in Japanese). Saishin Igaku 21:622–627
Scheffner D (1986) Fatal liver failure in children on valproate. Lancet II:511
Turnbull DM, Dick DJ, Wilson L, Sherratt HSA, Alberti KGMM (1986) Valproate causes metabolic disturbance in normal man. J Neurol Neurosurg Psychiatry 49:405–410
Ware S, Millward-Sadler GH (1980) Acute liver disease associated with sodium valproate. Lancet II:1110–1113
Young RSK, Bergman I, Gang DL, Richardson EP Jr (1980) Fatal Reye-like syndrome associated with valproic acid. Ann Neurol 7:389
Zimmerman HJ, Ishak KG (1982) Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2:591–597
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iinuma, K., Hayasaka, K., Narisawa, K. et al. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid. Eur J Pediatr 148, 267–269 (1988). https://doi.org/10.1007/BF00441418
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441418